NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
INTRODUCTION
In general, the scientific and biotechnology community has seen many breakthrough technologies in the last decade. Surprisingly, there is a big gap between the initial introduction of new platforms and their further application and commercial success. Many analysts and industry insiders are trying to understand the reasons why, in spite of technological advancement, the pharmaceutical industry does not provide more successful drugs and why certain technologies fail to advance or accelerate the drug discovery process.
It is important to note that biological and pathological conditions are very complex. Therefore, in order to understand properly the effect of a technology or platform in drug discovery application, the market should be divided into main categories such as, for example, genomics or proteomics-based approaches and their related drug discovery technologies. Each sector has its novel trends and challenges that affect the drug discovery market in general and specific segments in particular.
Market participants vary among the different niches in the drug discovery industry. There is also a clear division between technology developers, manufacturer/ suppliers, and biotech companies. Each type of market participant has a different business strategy and is affected differently by positive or negative drivers discussed in this report.
In summary, this report will highlight the main aspects, sectors, and trends in the drug discovery technologies market, the major market participants, and the current and future trends in each sector. Drivers and challenges in each segment of the industry will be discussed in detail including forecasts for the next five years.
In a second phase, a series of semi-structured interviews was conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotech and pharmaceutical companies. Other resources included academic institutions and technology and consulting companies. These were a rich source of data. Subsequent analysis of the documents and interview notes was iterative.
INTENDED AUDIENCE
This report is intended for business development professionals, entrepreneurs and other investment groups in order to fully understand and properly evaluate each segment in the drug discovery technology market. It provides a company's corporate development department with new insight into competitors' positions and reveals new opportunities otherwise overlooked or less known to the public.
Original post:
Drug Discovery Technologies, BCC Research